Brock Binkowski

USPTO Granted Patents = 39 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 18)

Average Co-Inventor Count = 7.6

ph-index = 6

Forward Citations = 179(Granted Patents)

Company Filing History:

Wisconsin Alumni Research Foundation

patents

Years Active: 2010-2025

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435354 - -derived luciferases, novel coelenterazine substrates, and methods of use (2025-10-07),

2. 12367513 - Activation of bioluminescence by structural complementation (2025-07-22),

3. 12366572 - Activation of bioluminescence by structural complementation (2025-07-22),

4. 12215375 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2025-02-04),

5. 11899021 - Luciferase-based thermal shift assays (2024-02-13),

6. 11661623 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2023-05-30),

7. 11655247 - Nanoluc suicide substrates (2023-05-23),

8. 11567083 - Luciferase-based thermal shift assays (2023-01-31),

9. 11493504 - Activation of bioluminescene by structural complementation (2022-11-08),

10. 11214822 - Stabilized formulation for luminescent detection of luciferase and nucleoside phosphates (2022-01-04),

11. 10928400 - Luciferase-based thermal shift assays (2021-02-23),

12. 10836767 - Serum stable pro-coelenterazine analogues (2020-11-17),

13. 10774364 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2020-09-15),

14. 10648971 - Activation of bioluminescence by structural complementation (2020-05-12),

15. 10571471 - Luciferase-based thermal shift assays (2020-02-25),

Title: The Innovative Mind of Brock Binkowski

Introduction: Brock Binkowski, based in Sauk City, Wisconsin, is a prolific inventor with a remarkable portfolio of 36 patents. His work primarily focuses on the field of bioluminescence, where he has made significant advancements that contribute to various scientific applications.

Latest Patents: Among his latest patents, Binkowski has developed Oplophorus-derived luciferases and novel coelenterazine substrates. His patent includes an isolated polynucleotide encoding a modified luciferase polypeptide and substrates. Notably, the OgLuc variant polypeptide features at least 60% amino acid sequence identity to a specified sequence, along with at least one amino acid substitution. This innovation boasts enhanced luminescence, improved signal stability, and greater protein stability compared to its wild-type counterpart. Binkowski's work also encompasses luciferase-labeled polypeptide targets, which are instrumental in characterizing target/ligand engagement within cells and cell lysates.

Career Highlights: Throughout his career, Binkowski has made significant contributions to the biotechnology industry. He has been affiliated with reputable organizations such as Promega Corporation and the Wisconsin Alumni Research Foundation. His expertise and inventions have helped propel forward bioluminescent technologies that are used in various research applications.

Collaborations: Binkowski has worked alongside esteemed colleagues, including Keith V Wood and Lance P Encell, who have contributed to the innovative projects he has led. Their collaboration has enriched the research environment and resulted in groundbreaking advancements in the field.

Conclusion: Brock Binkowski stands out as a leading inventor in the realm of bioluminescent technologies. His impressive array of patents illustrates his dedication to advancing scientific research and applications. With continued innovative efforts, Binkowski is poised to remain an influential figure in his field, driving forward discoveries that will benefit numerous scientific communities.

This text is generated by artificial intelligence and may not be accurate.